UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

The Role of the APC/C and Its Coactivators Cdh1 and Cdc20 in Cancer Development and Therapy

Frontiers in genetics, 2022-06, Vol.13, p.941565-941565

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in Germany

Haematologica (Roma), 2020-12, Vol.105 (12), p.2872-2878

2020

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic Stem Cell Transplantation in Multiple Myeloma

Cancers, 2021-12, Vol.14 (1), p.55

2021

Link zum Volltext

Verfügbarkeit prüfen

Validation of the revised myeloma comorbidity index and other comorbidity scores in a multicenter German study group multiple myeloma trial

Haematologica (Roma), 2021-03, Vol.106 (3), p.875-880

2021

Link zum Volltext

Verfügbarkeit prüfen

Neue Daten zur Therapie des multiplen Myeloms, Hodgkin-Lymphoms, DLBCL und MDS

Im Fokus Onkologie, 2023-09, Vol.26 (4), p.28-31

2023

Link zum Volltext

Verfügbarkeit prüfen

Validated single-tube multiparameter flow cytometry approach for the assessment of minimal residual disease in multiple myeloma

Haematologica (Roma), 2020-10, Vol.105 (10), p.e523-e523

2020

Link zum Volltext

Verfügbarkeit prüfen

Datenupdates zum multiplen Myelom und Mantelzelllymphom

Im Fokus Onkologie, 2022-09, Vol.25 (4), p.56-57

2022

Link zum Volltext

Verfügbarkeit prüfen

Effective Eradication of Glioblastoma Stem Cells by Local Application of an AC133/CD133-Specific T-cell-Engaging Antibody and CD8 T Cells

Cancer research (Chicago, Ill.), 2015-06, Vol.75 (11), p.2166-2176

2015

Link zum Volltext

Verfügbarkeit prüfen

Two cases of carfilzomib-induced thrombotic microangiopathy successfully treated with Eculizumab in multiple myeloma

BMC nephrology, 2021-01, Vol.22 (1), p.32-7, Article 32

2021

Link zum Volltext

Verfügbarkeit prüfen

In search for cure of multiple myeloma

Haematologica (Roma), 2023-11

2023

Link zum Volltext

Verfügbarkeit prüfen

Choosing the Right Therapy for Patients with Relapsed/Refractory Multiple Myeloma (RRMM) in Consideration of Patient-, Disease- and Treatment-Related Factors

Cancers, 2021-08, Vol.13 (17), p.4320

2021

Link zum Volltext

Verfügbarkeit prüfen

Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure

Blood cancer journal (New York), 2023-12, Vol.13 (1), p.179-179, Article 179

2023

Link zum Volltext

Verfügbarkeit prüfen

A Rationale to Enhance the Response to Antimitotic Therapy in Acute Myeloid Leukemia

Blood, 2012-11, Vol.120 (21), p.1332-1332

2012

Link zum Volltext

Verfügbarkeit prüfen

Ten Color Multiparameter Flow Cytometry in Bone Marrow and Apheresis Products for Assessment and Outcome Prediction in Multiple Myeloma Patients

Frontiers in oncology, 2021-08, Vol.11, p.708231-708231

2021

Link zum Volltext

Verfügbarkeit prüfen

Cellular and Humoral SARS-CoV-2 Vaccination Responses in 192 Adult Recipients of Allogeneic Hematopoietic Cell Transplantation

Vaccines (Basel), 2022-10, Vol.10 (11), p.1782

2022

Link zum Volltext

Verfügbarkeit prüfen

AML: Zytogenetik dominiert molekulares Risiko

Im Fokus Onkologie, 2020-04, Vol.23 (2), p.41-42

2020

Link zum Volltext

Verfügbarkeit prüfen

Intratibial injection of human multiple myeloma cells in NOD/SCID IL-2Rγ(null) mice mimics human myeloma and serves as a valuable tool for the development of anticancer strategies

PloS one, 2013-11, Vol.8 (11), p.e79939-e79939

2013

Link zum Volltext

Verfügbarkeit prüfen

The 3' untranslated region of the cyclin B mRNA is not sufficient to enhance the synthesis of cyclin B during a mitotic block in human cells

PloS one, 2013-09, Vol.8 (9), p.e74379

2013

Link zum Volltext

Verfügbarkeit prüfen

Conditional Survival Analysis in a Large Cohort of Multiple Myeloma Patients Provides Detailed Information about Long-Term Survival and Constitutes a Different Way to Identify Patients with Extended Life Expectancy

Blood, 2012-11, Vol.120 (21), p.4982-4982

2012

Link zum Volltext

Verfügbarkeit prüfen

Novel immunotherapies in multiple myeloma – chances and challenges

Haematologica (Roma), 2021-10, Vol.106 (10), p.2555-2565

2021

Link zum Volltext

Verfügbarkeit prüfen

Carfilzomib, lenalidomide, and dexamethasone maintenance for multiple myeloma: when and for whom?

The lancet oncology, 2023-02, Vol.24 (2), p.118-119

2023

Link zum Volltext

Verfügbarkeit prüfen

Monitoring APC/C activity in the presence of chromosomal misalignment in unperturbed cell populations

Cell cycle (Georgetown, Tex.), 2012-01, Vol.11 (2), p.310-321

2012

Link zum Volltext

Verfügbarkeit prüfen

Palbociclib in Acute Leukemias With KMT2A‐rearrangement: Results of AMLSG 23‐14 Trial

HemaSphere, 2023-05, Vol.7 (5), p.e877-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

S192: TALQUETAMAB (TAL) + DARATUMUMAB (DARA) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED TRIMM‐2 RESULTS

HemaSphere, 2023-08, Vol.7 (S3), p.e90062ca-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 242

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(216)
Mit Volltextzugriff
(216)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(231)
Deutsch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Role of the APC/C and Its Coactivators Cdh1 and Cdc20 in Cancer Development and Therapy

Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in Germany

Allogeneic Stem Cell Transplantation in Multiple Myeloma

European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma

Validation of the revised myeloma comorbidity index and other comorbidity scores in a multicenter German study group multiple myeloma trial

Neue Daten zur Therapie des multiplen Myeloms, Hodgkin-Lymphoms, DLBCL und MDS

Validated single-tube multiparameter flow cytometry approach for the assessment of minimal residual disease in multiple myeloma

Datenupdates zum multiplen Myelom und Mantelzelllymphom

Effective Eradication of Glioblastoma Stem Cells by Local Application of an AC133/CD133-Specific T-cell-Engaging Antibody and CD8 T Cells

Two cases of carfilzomib-induced thrombotic microangiopathy successfully treated with Eculizumab in multiple myeloma

In search for cure of multiple myeloma

Choosing the Right Therapy for Patients with Relapsed/Refractory Multiple Myeloma (RRMM) in Consideration of Patient-, Disease- and Treatment-Related Factors

Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure

A Rationale to Enhance the Response to Antimitotic Therapy in Acute Myeloid Leukemia

Ten Color Multiparameter Flow Cytometry in Bone Marrow and Apheresis Products for Assessment and Outcome Prediction in Multiple Myeloma Patients

Cellular and Humoral SARS-CoV-2 Vaccination Responses in 192 Adult Recipients of Allogeneic Hematopoietic Cell Transplantation

AML: Zytogenetik dominiert molekulares Risiko

Intratibial injection of human multiple myeloma cells in NOD/SCID IL-2Rγ(null) mice mimics human myeloma and serves as a valuable tool for the development of anticancer strategies

The 3' untranslated region of the cyclin B mRNA is not sufficient to enhance the synthesis of cyclin B during a mitotic block in human cells

Conditional Survival Analysis in a Large Cohort of Multiple Myeloma Patients Provides Detailed Information about Long-Term Survival and Constitutes a Different Way to Identify Patients with Extended Life Expectancy

Novel immunotherapies in multiple myeloma – chances and challenges

Carfilzomib, lenalidomide, and dexamethasone maintenance for multiple myeloma: when and for whom?

Monitoring APC/C activity in the presence of chromosomal misalignment in unperturbed cell populations

Palbociclib in Acute Leukemias With KMT2A‐rearrangement: Results of AMLSG 23‐14 Trial

S192: TALQUETAMAB (TAL) + DARATUMUMAB (DARA) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED TRIMM‐2 RESULTS

Suchergebnisse filtern